Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)
Clinical trial NCT05383209 · COMPLETED
Trial details
- NCT number
- NCT05383209
- Sponsor
- EyePoint Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-28
- Primary completion
- 2024-02-12
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.